Sean Dodge
Stock Analyst at RBC Capital
(2.34)
# 2,474
Out of 4,712 analysts
137
Total ratings
41.38%
Success rate
-1.92%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $199.99 | +35.01% | 5 | Dec 11, 2024 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $95.68 | +9.74% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $13.55 | +25.46% | 10 | Nov 21, 2024 | |
| AGL agilon health | Reiterates: Outperform | $3 | $1.91 | +57.07% | 6 | Nov 19, 2024 | |
| OPRX OptimizeRx | Maintains: Outperform | $14 → $7 | $4.94 | +41.70% | 10 | Nov 14, 2024 | |
| EVH Evolent Health | Reiterates: Outperform | $20 | $11.27 | +77.46% | 8 | Nov 12, 2024 | |
| WAY Waystar Holding | Maintains: Outperform | $31 → $34 | $37.76 | -9.96% | 2 | Nov 7, 2024 | |
| HCAT Health Catalyst | Maintains: Sector Perform | $8 → $9 | $6.90 | +30.43% | 8 | Nov 7, 2024 | |
| CDMO Avid Bioservices | Downgrades: Sector Perform | $12 → $13 | $12.26 | +1.96% | 14 | Nov 7, 2024 | |
| TDOC Teladoc Health | Maintains: Outperform | $9 → $10 | $9.26 | +7.99% | 15 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sector Perform | $23 | $25.19 | -8.69% | 14 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $19.02 | -26.39% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $4.49 | +122.72% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $19.90 | +40.70% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $11.51 | +21.63% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $170.49 | -80.64% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $990 → $180 | $1.45 | +12,313.79% | 2 | Mar 9, 2022 |
IQVIA Holdings
Dec 11, 2024
Reiterates: Outperform
Price Target: $270
Current: $199.99
Upside: +35.01%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $95.68
Upside: +9.74%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $13.55
Upside: +25.46%
agilon health
Nov 19, 2024
Reiterates: Outperform
Price Target: $3
Current: $1.91
Upside: +57.07%
OptimizeRx
Nov 14, 2024
Maintains: Outperform
Price Target: $14 → $7
Current: $4.94
Upside: +41.70%
Evolent Health
Nov 12, 2024
Reiterates: Outperform
Price Target: $20
Current: $11.27
Upside: +77.46%
Waystar Holding
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $37.76
Upside: -9.96%
Health Catalyst
Nov 7, 2024
Maintains: Sector Perform
Price Target: $8 → $9
Current: $6.90
Upside: +30.43%
Avid Bioservices
Nov 7, 2024
Downgrades: Sector Perform
Price Target: $12 → $13
Current: $12.26
Upside: +1.96%
Teladoc Health
Oct 9, 2024
Maintains: Outperform
Price Target: $9 → $10
Current: $9.26
Upside: +7.99%
Sep 27, 2024
Reiterates: Sector Perform
Price Target: $23
Current: $25.19
Upside: -8.69%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $19.02
Upside: -26.39%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $4.49
Upside: +122.72%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $19.90
Upside: +40.70%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $11.51
Upside: +21.63%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $170.49
Upside: -80.64%
Mar 9, 2022
Maintains: Sector Perform
Price Target: $990 → $180
Current: $1.45
Upside: +12,313.79%